Jeff Voigt WG85
Principal, Medical Device Consultants of Ridgewood
Jeff Voigt is the principal of Medical Device Consultants of Ridgewood, a firm dedicated to ensuring appropriate coverage and payment policies for medical technology companies (mainly earlier stage) and insurers. His expertise also includes healthcare analytics and evidence assessments, to assist policymakers in developing coverage for technologies that provide value. Jeff has published numerous articles on evidence assessments and health policy commentary in peer reviewed journals. His education includes: a bachelor’s degree from the University of Vermont, a Master of Public Health from Columbia, and a Master of Business Administration from the Wharton School.-
Dying in America
Is our health care system adequately helping people prepare for death? Expert panelists discuss end-of-life care and ways it can be improved.
-
How To Increase Participation in Cancer Trials
Despite their interest in doing so, most cancer patients do not enroll in clinical trials. A panel of experts discusses challenges and solutions...
-
Challenges and Solutions For Elder Care
With the senior population increasing dramatically, caring for them at home isn't just the cheapest method—it might be the most effective,...
-
Is Direct Primary Care a Viable Alternative?
The author and an expert panel examine the future of DPC as physicians and patients look beyond "fee for service" model of health care.
-
The Transformative Impact of the Chronic Care Act
The elderly special needs population now has more options for long-term care outside of traditional health services.
-
The Future of Artificial Intelligence in Medicine
Experts discuss how A.I. and evidence-based medicine will soon be an inevitable part of patient care
-
A Closer Look at Obstructive Sleep Apnea
Three sleep experts discussed this widely undertreated condition on Wharton Business Radio's "The Business of Health Care"
-
Using the Body’s Immune System to Fight Cancer
Three Penn Medicine doctors are developing T cell immunotherapy and vaccines to combat cell mutations that can lead to cancer.
-
Two Conditions Driving Up Health Care Costs
Hypertension and diabetes, among other factors, are contributing to skyrocketing rates. Is over-diagnosing and over-treating part of the problem?
-
The Future of Corporate Governance in Health Care
As the industry evolves, the boards of health care companies must become more engaged.
-
Evaluating Health Care Insurers
An inside look at how ratings agencies like the NCQA and A.M. Best assess health insurance companies.
-
The Gene Therapy Revolution: Great Promise, Great Challenges
The University of Pennsylvania is positioned to lead the way in this exciting field.
-
Caring For The Caregivers
Benefits and resources for the more than 40 million in-home family care providers is a hot—and complex—topic.
-
How Health Care Payers are Optimizing Treatment
Experts weigh in on appropriate use criteria and its quality control impact from the health insurer's perspective.
-
Cardiac Medicine May Solve the Inappropriate Care Crisis
Innovations in the field may offer relief for the U.S. health system's $700 billion inappropriate care crisis.
-
Why Inappropriate Health Care is a $700 Billion Problem
"The Business of Health Care" program on Wharton Business Radio explored the problems behind inappropriate health care.
-
How to Pay For Effective But High-Cost Treatments
"The Business of Health Care" program on Business Radio Powered by the Wharton School tackled this complex, critical topic.
-
Physician Leadership in the Affordable Care Act Era
Why physician leadership has been lacking and what Wharton is doing to reverse the trend.
-
Cognitive Computing in Health Care
Self-learning systems could soon revolutionize medicine and patient care.
-
Joe Biden’s Cancer Moonshot
The former vice president teams up with Penn and Wharton to pursue an aggressive health care initiative and search for a cure.
-
Making our Health Care System Healthy
Innovation through retail clinics, physicians treating health instead of illness.
-
What’s Next After Obamacare?
Trumpcare is likely to incorporate a number of the positive attributes of Obamacare. The question is, will Trumpcare embrace value analysis?
-
The Myth of Single-Bed Hospital Rooms
Jeff Voigt reviews the clinical evidence surrounding the need for single bed hospital rooms.
-
Taking a Closer Look at Value Based Reimbursements
Are value based reimbursements just fee for service with footnotes? Jeff Voigt explains.
-
Factors Associated with Hospital Profitability
Jeff Voigt discusses trends in hospital performance and profitability.
-
How Consumers Are Choosing Their Health Care Providers
Jeff Voigt examines the resources available for consumers choosing a health care provider and if consumers are really utilizing these resources...
-
The Maryland Global Budget Payment Program
Jeff Voigt of Medical Device Consultants Ridgewood discusses the Maryland Global Budget Program and the ways in which it's changing the health...
-
Health Literacy – What Is It and What Does It Mean for Our Health?
Jeff Voigt discusses the importance of health literacy, citing a recent broadcast from Business Radio on SirusXM.
-
‘Business of Health Care’ on Kindled Kidneys
Regenerative medicine is an exciting and expanding area already estimated at $18 billion. “The Business of Health Care” generates debate...
-
Coming to an Innovation District Near You
Philadelphia is home to a growing innovation district in health care for five key reasons. Perhaps a sixth—an energy and thirst for knowledge...
-
Wharton Business Radio Debates Personalized Medicine
The molecular diagnostics that fuels personalized medicine raises questions in the health care community. Find out why on Wharton Business Radio.
-
How to Solve for Medical Superutilizers
Superutilizers make up 1 percent of the population but use upward of 30 percent of health care resources. Here’s one social model to tackle...
-
Passing the Health Care Buck
Is health insurance consolidation good for the consumer? Mounting evidence suggests that pricing and quality of care are negatively, and increasingly,...
-
The ‘Businefication’ of Medical Research
A dose of business principles, in large part from venture philanthropy, is changing the way medical research is done in the U.S. health care...
-
Winners and Losers in Health Care Mergers
Are recent health care mergers a good thing? Who are the winners and losers in these deals? Jeff Voigt finds answers in research on past consolidations.
-
A Checkup on Medicaid’s $7 Billion Experiment
As part of the Affordable Care Act, primary care providers got paid more to take Medicaid patients. Did it work to provide better care to more...
-
Face to Face With Health Care Costs
A Wharton health care expert shares a recent scare with his father, when he learned firsthand how fragmented health care delivery is despite...
-
Health Care Management Through Medicaid?
Could health gains from the ACA be in jeopardy from reluctance to continue state-based Medicaid payments? A Wharton Health Care Management alum...
-
Academic Medical Centers Face a Tall Order
Academic medical centers face a long list of tasks to survive in the 21st century U.S. health care system, writes Wharton’s alumni health care...
-
Health Care Payment Models Not Ready for Prime Time
The U.S. federal government has rolled out new implementation goals for value-based health care payments. Are regulators moving too far, too...
-
Healthcare Tech: Putting Innovation at Stake?
Health information technology is hot, but its growth comes at the expense of medical devices, writes the health care-focused Wharton alumni club...
-
Can the ACA Fix the Primary Care Shortage?
With upward of 39 million more Americans receiving health care coverage through health care reform, will the system be able to meet the demand?
-
SiriusXM Business Radio: Health Care
Wharton alumni are right in the thick of meaty health care issues, like the cost of specialty drugs. Here’s a recap of some notable graduates...
-
Health Care Capitalism and Social Conscience
A celebration of the values and the people of Wharton’s Health Care Management Department.
-
Can Apple Watch Drive Health Wearables to Mainstream?
The health care capabilities of Apple’s ”most personal device ever” could boost a marketplace filled with promising startups, says a medical...
-
Debating the Value of High-Cost Drug Therapies Like Sovaldi
Health care expert Jeff Voigt looks at a controversial liver drug to illustrate the growing importance of medical cost-effectiveness.
-
Making Plain the Politics of Health Care
What does Massachusetts’ decision on Partners Healthcare mean for physicians and their patients? The Wharton Health Care Alumni Association...
-
Health Care Innovation Frustrated by Federal Regulation in Action
A Wharton blogger makes a call for greater transparency for the federal health care agency, particularly when patient outcomes and cost reductions...
-
Wharton Health Care Experts Star on SiriusXM
Listeners to Business Radio Powered by Wharton learn a lesson on health care deregulation and consolidation.
-
Evidence-Based Studies in Need of Replacement
What we need in U.S. health care are up-to-date analyses and better training. Here is an orthopedic example to illustrate why.
-
Beating Readmission
What are the true costs of heart failure in the United States? If we knew this, physicians could better treat it.
-
Diagnosing How Health Care Dollars Get Spent
Data explains why where you live affects what you pay for health care.
-
-
The New Health Care Sales Paradigm
Health care reform has led drugmakers and hospital systems to carry out more rigorous cost-benefit value analyses. Take the experience of two...
-
Data Raises Questions in Health Care
The promise of big data in providing value to our health care system lies in delivering the right data at the right time to the right person.
-
Healthy Application Innovation
Three steps to mobile health care innovations and how developers can provide value.
-
Preparing for a Premier Health Care Event on Campus
Value creation in health care is likely to come from innovation. Come and meet some of the people behind the change.
-
An Oxymoron: Service and Doctors?
Customer service as part of the health care experience is about to have a lot more value to caregivers as health reform gets under way.
-
The Coming Cost-Effectiveness of Cancer Care
The U.S. is likely to follow the U.K.’s lead in imposing cost discipline to cancer therapy.
-
The Oncological Dilemma
For society, medical providers and people receiving cancer care, serious questions remain about the "value" of treatment.
-
Two Ways to Tackle the High Cost of Cancer
We continue our exploration of the issues surrounding the value of cancer treatment to society and individuals.
-
Cutting the Waste in the Cancer Chase
Is the arms race in the genetic mapping of cancer worth the investment? Cost-effectiveness analysis could provide our answer.
-
Taking Responsibility for Health Care Reform
It’s not just the government’s role to allocate health care resources properly. It is time for all relevant parties to think rationally.
-
Three Policies for Cost-Effective Healthcare
The U.S. federal government has new ways to reduce waste in Medicare and across the health care system.
-
Moneyball for Health Care: Part 2
The medical community’s mindset and financing continue to explain why health care is plagued with inefficient allocation of resources.
-
Moneyball for Health Care
The inefficient allocation of resources explains why so many Medicare dollars are squandered. Here’s a simple example to explain how it happens.